![]() |
MCC-950
- 英文名称:MCC-950
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10862
- cas:210826-40-7
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10862 |
用途 | 科研检测 |
英文名称 | MCC-950 |
包装规格 | 1MG |
CAS编号 | 210826-40-7 |
别名 | MCC-950 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C20H23N2O5S ? Na
分子量:426.46
溶剂:DMSO (40 mg/ml) Water (30 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):NLRP3 inflammasome inhibitor
Function / Pharmacology:MCC-950 was originally found to act as a cytokine release inhibitory drug (CRID), arresting activated monocytes and preventing activation of caspase-11. Discovered to be a novel inhibitor of the NLRP3 and AIM2 inflammasomes2. Blocks canonical and noncanonical NLRP3 activation at nanomolar concentrations3. Inhibits interleukin 1β (IL-1β) secretion in vivo and attenuates the severity of experimental autoimmune encephalomyelitis (an MS disease model)3. Disrupts the interaction between AIM2 and ASC in a reconstituted cell-free inflammasome4. A valuable new tool for exploring the pathophysiology of NLRP3.
分子式:C20H23N2O5S ? Na
分子量:426.46
溶剂:DMSO (40 mg/ml) Water (30 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):NLRP3 inflammasome inhibitor
Function / Pharmacology:MCC-950 was originally found to act as a cytokine release inhibitory drug (CRID), arresting activated monocytes and preventing activation of caspase-11. Discovered to be a novel inhibitor of the NLRP3 and AIM2 inflammasomes2. Blocks canonical and noncanonical NLRP3 activation at nanomolar concentrations3. Inhibits interleukin 1β (IL-1β) secretion in vivo and attenuates the severity of experimental autoimmune encephalomyelitis (an MS disease model)3. Disrupts the interaction between AIM2 and ASC in a reconstituted cell-free inflammasome4. A valuable new tool for exploring the pathophysiology of NLRP3.